18 research outputs found
United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)
Background:There have been substantial improvements in the management of chronic pancreatitis, leading to the publication of several national guidelines during recent years. In collaboration with United European Gastroenterology, the working group on Harmonizing diagnosis and treatment of chronic pancreatitis across Europe' (HaPanEU) developed these European guidelines using an evidence-based approach. Methods: Twelve multidisciplinary review groups performed systematic literature reviews to answer 101 predefined clinical questions. Recommendations were graded using the Grading of Recommendations Assessment, Development and Evaluation system and the answers were assessed by the entire group in a Delphi process online. The review groups presented their recommendations during the 2015 annual meeting of United European Gastroenterology. At this one-day, interactive conference, relevant remarks were voiced and overall agreement on each recommendation was quantified using plenary voting (Test and Evaluation Directorate). After a final round of adjustments based on these comments, a draft version was sent out to external reviewers. Results: The 101 recommendations covered 12 topics related to the clinical management of chronic pancreatitis: aetiology (working party (WP)1), diagnosis of chronic pancreatitis with imaging (WP2 and WP3), diagnosis of pancreatic exocrine insufficiency (WP4), surgery in chronic pancreatitis (WP5), medical therapy (WP6), endoscopic therapy (WP7), treatment of pancreatic pseudocysts (WP8), pancreatic pain (WP9), nutrition and malnutrition (WP10), diabetes mellitus (WP11) and the natural course of the disease and quality of life (WP12). Using the Grading of Recommendations Assessment, Development and Evaluation system, 70 of the 101 (70%) recommendations were rated as strong' and plenary voting revealed strong agreement' for 99 (98%) recommendations. Conclusions:The 2016 HaPanEU/United European Gastroenterology guidelines provide evidence-based recommendations concerning key aspects of the medical and surgical management of chronic pancreatitis based on current available evidence. These recommendations should serve as a reference standard for existing management of the disease and as a guide for future clinical research
The impact of constructive feedback on training in gastrointestinal endoscopy using high-fidelity virtual- reality simulation: a randomised controlled trial
virtual-reality simulation: a randomised controlled trial gastrointestinal endoscopy using high-fidelit
Pathophysiology and management of opioid-induced constipation: European expert consensus statement
Background: Opioid-induced bowel dysfunction is a complication of opioid therapy, in which constipation is the most
common and problematic symptom. However, it is frequently under-recognised and thus effective management is often
not instituted despite a number of treatment options.
Objective: The central objective of this study is to provide a summary of the pathophysiology and clinical evaluation of
opioid-induced constipation and to provide a pragmatic management algorithm for day-to-day clinical practice.
Methods: This summary and the treatment algorithm is based on the opinion of a European expert panel evaluating current
evidence in the literature.
Results: The pathophysiology of opioid-induced constipation is multi-faceted. The key aspect of managing opioid-induced
constipation is early recognition. Specific management includes increasing fluid intake, exercise and standard laxatives as
well as addressing exacerbating factors. The Bowel Function Index is a useful way of objectively evaluating severity of
opioid-induced constipation and monitoring response. Second-line treatments can be considered in those with recalcitrant
symptoms, which include gut-restricted or peripherally acting mu-opioid receptor antagonists. However, a combination of
interventions may be needed.
Conclusion: Opioid-induced constipation is a common, yet under-recognised and undertreated, complication of opioid
therapy. We provide a pragmatic step-wise approach to opioid-induced constipation, which should simplify management
for clinicians.status: publishe